Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presurgical Treatment With Ribociclib and Letrozole in Patients With Locally Advanced Breast Cancer: the NEOLETRIB Study.

NCT05163106 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT05163106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05163106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presurgical Treatment With Ribociclib and Letrozole in Patients With Locally Advanced Breast Cancer: the NEOLETRIB Study.
Lead sponsor
University Hospital, Akershus
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2022
Completion date
July 30, 2024
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, er-positive breast cancer, her2-negative breast cancer, locally advanced breast cancer, luminal a breast cancer, luminal b breast cancer